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Abstract
Introduction: Carpal tunnel syndrome (CTS) is the most common peripheral nerve entrapment. 
Various treatments have been suggested for CTS and there is no consensus on their superiority and 
the order of their use. Laser therapy is a non-invasive treatment method for many musculoskeletal 
diseases, including CTS. This study aimed to determine and compare the effect of high-power lasers 
(HPLs) and low-power lasers (LPLs) on pain severity, function, pinch strength, and nerve conduction 
study findings in patients aged 30-50 years with mild or moderate CTS.
Methods: This is a prospective, randomized, single-blind clinical trial. The study population 
included 45 patients aged 30-50 years who came to the physical medicine and rehabilitation clinic 
of Shohada-e-Tajrish hospital and mild or moderate CTS was confirmed for them. Patients were 
randomly assigned to control, LPL therapy, and HPL therapy groups. Pain, function, pinch strength, 
and nerve conduction study findings were recorded in all groups before, immediately and 12 weeks 
after the treatment. All data were compared using SPSS version 21. 
Results: All groups showed improvement regarding pain, function, and pinch strength. Laser therapy 
showed significantly better results compared to a wrist splint, but no significant difference was seen 
between high-power and LPL therapy groups. Nerve conduction evaluation findings did not reveal 
any significant difference.
Conclusion: Both the wrist splint and laser therapy can improve the symptoms of carpal tunnel 
syndrome. HPL therapy showed better results, although not significantly different from LPL therapy.
Keywords: Carpal tunnel syndrome; High-intensity laser therapy; Low-intensity laser therapy; 
Electrodiagnostic evaluation.
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Introduction
Carpal tunnel syndrome (CTS) is the most common 
peripheral nerve entrapment, which is caused by the 
median nerve compression in the wrist and affects 
millions around the world.1,2 The carpal tunnel consists of 
wrist bones and transverse ligaments (flexor retinaculum) 
in the anterior part of the wrist and the median nerve 
passes through this space with 9 tendons. Due to its 
specific position in the tunnel, the median nerve is highly 
prone to compression.3 The annual prevalence of CTS is 
estimated to be around 2.1% in the general population,4 
with women more affected than men.5 Most patients 
complain of numbness, tingling, and pins and needles in 
the median nerve sensory innervation territory, which 
may get worse when sleeping at night.6,7 In the advanced 
stages of the disease, the atrophy of the thenar muscles 
occurs, accompanied by the weakness of the thumbs and 
index fingers, leading to the inability to hold objects by 
hand.8
This syndrome can be suspected in a patient according 
to history and physical examination, but the gold 
standard diagnostic method is using electrodiagnosis, 
which is vitally important in the diagnosis and assessment 
of the severity (which is necessary for choosing the 
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treatment method) and is also helpful for ruling out other 
neuropathic disorders (such as radiculopathy, plexopathy 
or other peripheral nerve lesions.9
Many therapeutic methods have been suggested for 
CTS and there is no consensus on their superiority and the 
order of their use.10 Conservative treatments are the main 
therapeutic approaches in the first step. Conservative 
treatments include wrist splints, steroid injections in 
the carpal tunnel, anti-inflammatory medications, 
mobilization techniques, and physical modalities such as 
laser therapy, ultrasound and Bioptron.11-14  Carpal tunnel 
surgery is preserved for the severe involvement and the 
patients who are refractory to conservative therapy.15,16 
Wrist splinting, as a method of avoiding further injury, is 
one of the most common treatments among CTS patients 
and has been endorsed by the American Academy of 
Orthopedic Surgeons (AAOS) clinical practice guideline 
published in 2009.17 Among various physical modalities, 
laser therapy and ultrasound methods may have potential 
effects on bringing about biophysical effects within 
tissues.18
These results accelerate the wound healing process, as 
well as a significant reduction in pain, inflammation, and 
scarring in the tissues. The particles of laser energy are 
absorbed by a variety of molecules within the cell, a process 
that initiates several positive physiological responses.19 In 
essence, light energy is converted into biochemical energy. 
As a result, normal cell morphology and function are 
restored. The process is curative.20 Low-power laser (LPL) 
therapy is a non-invasive treatment method for many 
neuromusculoskeletal diseases. It is mainly believed that 
it can reduce pain and local inflammation by stimulating 
the micro vascularization and blocking pain enzymes and 
activating endorphins.21,22 Many studies have assessed the 
effect of LPL therapy on peripheral nerve injuries because 
it increases microcirculation in the tissue, promotes 
nerve function, increases the rate of axon growth and 
myelinization, and improves regeneration of the injured 
nerve.23 The high-power laser (HPL) is a technological 
advancement in the LPL field and can treat a much larger 
part of the body surface. Furthermore, it has deeper 
penetration and consumes less time compared with the 
LPL. The HPL or hot laser is 24 times more powerful than 
conventional lasers and its effective penetration depth 
is more than 4 centimeters, while LPL has an effective 
penetration depth of half a centimeter and can mainly 
help treat superficial and small tissues.24 The HPL is 
painless and safe and has no side effects. An increase in 
localized temperature can be observed in the skin due to 
laser penetration.25 
Notwithstanding all these, laser therapy still faces 
many controversies, especially in neuromusculoskeletal 
disorders such as CTS. It is due to the lack of enough 
studies on this subject. To fill this lacuna, the present 
study aims to investigate and compare the effect of HPL 
on the CTS treatment process to determine whether HPL 
has moderate superiority over LPL therapy or splinting 
in relieving pain, grip strength, and electrodiagnosis in 
patients aged 30-50 years with mild and moderate CTS.
Materials and Methods
This is a prospective, single-blind clinical trial that 
was conducted in Shohada-e-Tajrish hospital between 
February and December 2018. This study was 




The study population included all patients who came 
to the clinic of physical medicine and rehabilitation 
of Shohada-e-Tajrish hospital between February and 
December 2018 with signs and symptoms of CTS. The 
diagnosis of CTS was confirmed by electrodiagnostic 
studies (nerve conduction study and electromyography). 
Patients with confirmed mild or moderate CTS were 
selected. The patients were informed about the plan and 
goals of the study as well as its possible complications by a 
physician, and the informed consent form was completed 
by them. Inclusion criteria included patients from 30-50 
years of age and the duration of symptoms for at least 3 
months. Exclusion criteria included (1) The presence 
of other neuropathic diseases such as polyneuropathy, 
cervical radiculopathy or brachial plexopathy (including 
thoracic outlet syndrome), (2) Systemic diseases that can 
affect the severity or treatment, such as hypothyroidism, 
gout, systemic lupus erythematosus, rheumatoid arthritis, 
diabetes mellitus, chronic kidney deficiency, and 
acromegaly, (3) History of carpal tunnel release surgery, 
(4) Wrist fracture, (5) Pregnancy, (6) History of injection 
in the carpal tunnel in the last month.
Randomization and Sampling
A non-probability randomized (quota) sampling method 
was used. Forty-five patients with confirmed mild or 
moderate CTS were enrolled in the study, considering 
their willingness to enter the study. Then 15 patients were 
randomly assigned to the control group, 15 patients to the 
LPL group, and 15 patients to the HPL group.
Blinding
This is a single-blind study. A physician (specialist in 
physical medicine and rehabilitation) who was blinded to 
the patient’s group was in charge of the electrodiagnostic 
assessment and collecting data of all patients (including 
demographic data, visual analog scale [VAS], Boston 
questionnaire, grip strength, and electrodiagnosis 
findings). Moreover, he gave instructions about using the 
wrist splint to all participants. A separate physician did 
the HPL therapy and a therapist did the low-level laser 
therapy, both blinded to patients’ assessment. However, 
due to this limitation that we did not use a sham laser, 
the patients could not be blinded, although the patients in 
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both laser therapy groups were blinded about the power 
of the laser emission they received.
Intervention
During the treatment, the patients did not use any 
medication, and care instructions were equally provided 
to the groups. The patients were randomly assigned to 
one of the treatment groups: wrist splint (control group), 
wrist splint + LPL, and wrist splint + HPL. A wrist splint 
with a metal bar was used at an angle of 0° for 12 weeks 
in each of the three treatment groups. The patients were 
instructed to wear the splint during the night and as long 
as they could during the day time. In the LPL group, 
the patients underwent LPL radiation using a Fisioline, 
Lumix 2 device (45 W) with a wavelength of 775 nm, a 
frequency of 6500 Hz, and an intensity of 20 J/cm2 on the 
carpal tunnel region (along with the flexor retinaculum, 
just distal to wrist palmar crease). In the HPL group, 
the laser was applied using the BTL-6000 device, with 
a wavelength of 1064 nm, an intensity of 20 J/cm2, and 
5-W power, for 36 seconds, to the same anatomic region 
similar to the LPL group. No topical lotion or ointment 
was used during laser therapy. Eye protection glasses were 
used during laser therapy by both the patient and the 
physician. The results were evaluated immediately and 12 
weeks after the treatment.
Data Collection
The numeric VAS was used for pain assessment, ranging 
from 0 (No pain) to 10 (the most severe pain imaginable). 
Pinch strength was measured by a manual dynamometer 
(Hydraulic pinch gauge, Saehan Company, South Korea). 
The patient was in a comfortable sitting position during the 
measurement and the mean force generated in 3 attempts 
was calculated and recorded. The electrodiagnostic 
evaluation was done using the UltraPro S100 device 
(Natus Company, Denmark), including the assessment 
of median nerve sensory action potential (sensory nerve 
action potential or SNAP) and motor action potential 
(compound motor action potential or CMAP).  SNAP 
peak latency (PL) and amplitude (amp) and CMAP onset 
latency (OL), amplitude, and nerve conduction velocity 
(NCV) were measured and recorded for each patient. 
The severity of symptoms and the functional status of the 
patients were evaluated using the Boston questionnaire. 
The Boston questionnaire consists of two parts: measuring 
the severity of symptoms and measuring the patient’s 
functional status. BQ-SS: Boston Symptom Severity 
Scale (BQ-SS) consists of 11 questions about the severity 
and frequency of symptoms, including night and day 
numbness, pins and needles, pain, and muscle weakness. 
BQ-FS: Boston Questionnaire Functional Scale (BQ-FS) 
consists of 8 questions concerning the patient’s problems 
in performing specific activities such as writing, holding a 
book, buttoning up the shirt, holding the phone, opening 
jam jar, doing hard house chores, taking a bath, carrying a 
shopping bag, and dressing. Each question was answered 
using a 5-point Likert scale that consists of 5 options 
and each option is assigned a score ranging from 1 to 5, 
with scores 1 indicating no symptoms and 5 indicating 
the most severe symptoms. To determine the severity of 
symptoms and functional status, the mean scores were 
calculated in each part. The higher the mean score, the 
greater the severity of the symptoms, and the disability of 
the patient would be. Thus, the patients were divided into 
5 groups based on the score obtained: 1. healthy (0.1-1), 
2. mild (1.1-2), 3. moderate (2.1- 3), 4. severe involvement 
(3.1-4), and 5. very severe involvement (4.1-5). 
Individuals who were literate enough filled out a 
questionnaire by themselves, but the questionnaire was 
read face to face for those people with lower literacy and 
reading difficulties. 
All of the variables were measured before the treatment 
and immediately and 12 weeks after the last treatment 
session. 
Data Analysis
All documented information was analyzed using SPSS 
version 21 and appropriate statistical tests were used for 
data analysis. A P value less than 0.05 was considered as 
statistically significant. 
Results
A total number of 63 patients were eligible for the study, 
but 13 were excluded (mainly due to the presence of 
radiculopathy), 2 did not meet the inclusion criteria (they 
had severe CTS) and 3 refused to participate. Finally, 45 
patients were enrolled (Figure 1). Demographic data were 
collected and compared between groups. All patients 
were women. The patients’ mean age, height, and weight 
in the control group were 46.9 ± 1.7 years, 159.1 ± 1.9 
cm, and 65 ± 2.6 kg respectively. The patients’ mean age, 
height, and weight in the LPL group were 48.7 ± 1.9 years, 
159.6 ± 2.22 cm, and 61± 2.4 kg respectively. The patients’ 
mean age, height, and weight in the HPL group were 46.9 
± 1.7 years, 159 ± 2.06 cm, and 63 ± 2.7 kg respectively. 
There was no significant difference between the 3 groups. 
P value<0.001 was considered statistically significant. 
Moreover, there was no significant difference between the 
3 groups in terms of mean pinch strength, pain severity 
(VAS and BQ-SS), functional status (BQ-FS), and the 
electrodiagnostic parameters before the therapeutic 
intervention (Table 1). 
In terms of pinch strength, all groups showed 
improvement in the follow-up sessions, both immediately 
and 12 weeks after the treatment; the change in the 
LPL and HPL groups was significant at both follow-up 
sessions (P < 0.001), but in the control group there were 
no significant changes seen immediately (P = 0.061) and 
12 weeks (P = 0.091) after the treatment. The highest 
mean pinch strength belonged to the HPL group, with a 
mean of 11.93 kg immediately and 12.12 kg 12 weeks after 
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the treatment; and the lowest mean strength was seen in 
the control group immediately and 12 weeks after the 
treatment, with a mean strength of 9.54 kg and 9.75 kg 
respectively (Figure 2).
The evaluation of VAS score changes immediately and 
12 weeks after the treatment period showed a significant 
decrement in all groups (P < 0.001) compared to the 
base evaluation, but there was no significant difference 
between the groups (P = 0.050). Patients in the HPL 
group had the lowest VAS scores, with a mean of 4.12 
immediately after treatment and 3.2, 12 weeks after the 
treatment; the highest scores were found in the control 
group with means of 7.46 and 6.73 immediately and 12 
weeks after the treatment respectively (Figure 3).
In terms of the symptoms severity scale, all three groups 
showed a significant improvement immediately and 12 
weeks after the treatment (P < 0.001), but there was no 
significant difference between the two groups (P = 0.123). 
The lowest score immediately after the treatment 
belonged to the HPL group (mean: 24), but 12 weeks after 
the treatment the lowest score was seen in the LPL group 
(mean:17) (Figure 4).
Assessing the functional status immediately and 
12 weeks after the treatment indicated a significant 
improvement in all groups (P < 0.001), with the lowest 
score (better function) in the HPL group (13.2 and 10.2 
respectively). There was no significant difference between 
the LPL and HPL groups (P = 0.164). The minimum 
changes were seen in the control group, especially in the 
comparison between the 2 follow-up sessions (Figure 5).
Assessing the electrodiagnostic parameters, including 
sensory peak latency (SNAP PL), sensory amplitude 
(SNAP amp), motor onset latency (CMAP OL), motor 
amplitude (CMAP amp), and CMAP NCV, is provided 
below in turn. All numbers were rounded to one decimal 
place for easier evaluation. 
In terms of SNAP PL, all groups showed a very small 
decrement immediately and 12 weeks after the treatment, 
but none of them showed a significant improvement 
(P = 0.123) (Figure 6).
Assessing SNAP amp changes revealed no significant 
changes in all three groups (P = 0.624) (Figure 7).
Changes in CMAP OL were seen in all groups, with 
no significant differences. The changes did not indicate a 
certain trend; as it is seen in the HPL group, there was a 
minimal decrement immediately after the treatment but 
Figure 1. Consort table



































Assessed for eligibility 
(n = 63) 
Excluded (n = 13) 
  Not meeting inclusion criteria (n = 2) 
  Refused to participate (n = 3) 
Randomized (n = 45) 
Allocated to HPL 
group 






   
 
























Allocated to LPL 
group 






   
 
   
 
  
Allocated to Splint 
group 






   
 














Journal of Lasers in Medical Sciences  Volume 11, Suppl 1, Autumn 2020 S77
                                                               The Effect of Laser Therapy on Carpal Tunnel Syndrome
again an increment after 12 weeks (Figure 8).
The evaluation of CMAP amplitude showed changes in 
all three groups but not statistically significant (P = 0.164). 
The highest CMAP amp immediately and 12 weeks after 
the treatment was seen in the HPL group (7.5 and 7.7 mV 
respectively) (Figure 9).
Finally, CMAP NCV evaluation showed no certain 
trend, with no significant changes in any groups 
(P = 0.164). However, minimal improvement was seen 
in the LPL and HPL groups. The highest NCV was seen 
in the HPL group immediately (55.81 m/s) and 12 weeks 
(56.12 m/s) after the treatment (Figure 10).
Discussion
The purpose of this study was to compare the efficacy 
of low-power and HPL therapies on pain, function, 
and electrodiagnostic parameters in patients with mild 
or moderate CTS. For this purpose, the patients were 
randomly divided into three groups (control, LPL, and 
HPL groups). 
In the first stage, the patients’ age, height, and 
weight were measured and recorded, which showed no 
significant difference between the groups. Moreover, VAS, 
symptom severity scale, functional scale, pinch grip, and 
electrodiagnostic parameters were evaluated before the 
treatment (basis), immediately after the treatment (first 
follow-up session) and 12 weeks after (second follow-up 
session) the treatment. There was no significant difference 
regarding these evaluation findings between the three 
groups at the baseline assessment. The results were 
compared between the first and second follow-up sessions 
relative to each other and to the baseline assessment. The 
results were also compared between different groups.
As mentioned in the results section, the pain 
decreased in all 3 groups according to VAS and BQ-
SS evaluation, but there was no significant difference 
between the groups. The pain decrement could be due 
to wrist immobility, using the wrist splint in all groups. 
However, more decrement was seen in the laser therapy 
groups, which can propose the role of laser energy in 
decreasing pain, although no significant decrement 
was seen. Moreover, no significant difference was seen 
between the LPL and HPL groups, which can be due to 
Figure 2. Mean Pinch Strength.
Figure 3. VAS Score.
Figure 4. Symptom Severity Scale Score (BQ-SS).
Figure 5. Functional Status (BQ-FS).
Figure 6. Sensory peak latency
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the almost equal total energy radiated in both groups. 
Our study also showed functional improvement in all 
three groups but no significant difference between the 
groups. This should be noted that an improvement in 
function can be a direct result of pain decrement, so it 
looks logical that by decreasing the pain the function 
improves. In line with our study results, Rayegani et al8 
showed that low-level laser therapy resulted in a pain 
decrement and functional improvement in 50 patients 
with mild and moderate CTS. They also mentioned an 
improvement in electrodiagnostic parameters, although 
with no significance. In our study, the evaluation of the 
electrodiagnostic parameters showed variable results. 
This can most likely be due to technical errors and intra-
rater reliability, which are common in electrodiagnostic 
studies, although with no clinical significance in most 
cases. The results of Casale and colleagues’ study showed 
that positive and negative sensory symptoms improved 
by HPL therapy )a combination of the 830 nm and 1064 
nm laser wavelengths), leading to decreased pain, itch 
sensation as well as improvement in neuropsychological 
parameters. Moreover, their results showed better 
improvement than transcutaneous nerve electrical 
stimulation, but there was no statistically significant 
difference between these modalities.24
In our study, the HPL group showed more improvement 
in pinch strength, VAS, symptom severity scale 
(immediately after treatment), and functional status, 
but the difference was not significant compared to the 
LPL group. Both low-power and HPL therapy groups 
showed better results than the control group, in which 
improvement was seen, confirming the effect of wrist 
immobilizing and rest on CTS symptoms. Various studies 
have demonstrated that lasers can be effective in reducing 
pain. Reducing pain results in better function which is 
approved in our study. Moreover, we hope by using lasers 
we can see tissue repair, especially neural tissue in nerve 
injury cases such as CTS. Neural tissue improvement 
needs to be approved by electrodiagnostic studies, not 
only by a reduction in symptoms. We should remind 
that there are few studies on HPL therapy in the field 
of neuromuscular disorder treatment, because of which 
laser therapy parameter selection is still controversial. We 
decided to have total laser energy near to LPL therapy 
to keep the patients safe. This can have a major impact 
on the results of the study. More studies are needed on 
the high power-laser effects on human tissues, so we can 
write more confidently about its effects on various tissues, 
including neural tissue.
Conclusion
Both the wrist splint and laser therapy can improve 
the symptoms of CTS, leading to better function. HPL 
therapy showed better results, although not significantly 
different from LPL therapy.
Ethical Considerations
Figure 8. Motor Onset Latency.
Figure 9. Motor Amplitude.
Figure 10. Motor Nerve Conduction Velocity Changes.
 













































































Figure 7. Sensory amplitude
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